Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • News
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • News
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Elisa Assay Kit
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Elisa Assay Kit

[0544-MBS266877-96T] LMWH elisa Test :: Human low molecular weight heparin (LMWH) ELISA Test-96-Strip-Wells
LMWH elisa Test :: Human low molecular weight heparin (LMWH) ELISA Test-96-Strip-Wells
890.00 € 890.0 EUR
[0544-MBS733861-96T] LH elisa Test :: Fish Luteinizing Hormone (LH) ELISA Test, 96 tests
LH elisa Test :: Fish Luteinizing Hormone (LH) ELISA Test, 96 tests
980.00 € 980.0 EUR
[0544-MBS012684-96T] LEPTIN elisa Test :: Horse Leptin ELISA Test-96-Strip-Wells
LEPTIN elisa Test :: Horse Leptin ELISA Test-96-Strip-Wells
912.04 € 912.04 EUR
[0544-MBS021271-48] LEPTIN elisa Test :: Fish Leptin ELISA Test - 48-Strip-Wells
LEPTIN elisa Test :: Fish Leptin ELISA Test - 48-Strip-Wells
950.00 € 950.0 EUR
[0544-MBS280322-96T] LEP elisa Test :: Horse Leptin ELISA Test 96T
LEP elisa Test :: Horse Leptin ELISA Test 96T
1,176.00 € 1176.0 EUR
[0914-844101] LEGEND MAX Human α-Synuclein ELISA Test - 96 Tests
LEGEND MAX Human α-Synuclein ELISA Test - 96 Tests
739.20 € 739.2 EUR
[0544-MBS285418-96T] LE elisa Test :: Human Leukocyte esterase ELISA Test- 96-Strip-Wells
LE elisa Test :: Human Leukocyte esterase ELISA Test- 96-Strip-Wells
1,100.00 € 1100.0 EUR
[0544-MBS285418-5x96T] LE elisa Test :: Human Leukocyte esterase ELISA Test -  5x96-Strip-Wells
LE elisa Test :: Human Leukocyte esterase ELISA Test - 5x96-Strip-Wells
5,100.00 € 5100.0 EUR
[0544-MBS335481-96] Test IL-1 bêta - ELISA - 96 Wells
Test IL-1 bêta - ELISA - 96 Wells
650.00 € 650.0 EUR
[0544-MBS265649-96] Kim1 elisa Test :: Rat Kidney Injury Molecule 1 (Kim1) ELISA Test - 96 wells
Kim1 elisa Test :: Rat Kidney Injury Molecule 1 (Kim1) ELISA Test - 96 wells
724.00 € 724.0 EUR
[0544-MBS355395-96] Kim-1 elisa Test :: Rat Kim-1 ELISA Test - 96 wells
Kim-1 elisa Test :: Rat Kim-1 ELISA Test - 96 wells
769.00 € 769.0 EUR
[0544-MBS355384] Kim-1 Human ELISA Test - 96wells
Kim-1 Human ELISA Test - 96wells
665.50 € 665.5 EUR
[0513-DEIA048] Kanamycin ELISA Test, 96 tests
Kanamycin ELISA Test, 96 tests
1,645.00 € 1645.0 EUR
[0399-CSB-EFD1027696-96T] Kanamycin (KA) Elisa Test 96t
Kanamycin (KA) Elisa Test 96t
690.00 € 690.0 EUR
[0879-KBI1017] KRIBIOLISA Trastuzumab ELISA (HERCEPTIN)
KRIBIOLISA Trastuzumab ELISA (HERCEPTIN)
640.00 € 640.0 EUR
[0879-KBI1022] KRIBIOLISA Tocilizumab (ACTEMRA) ELISA - CE MARKED 96W
KRIBIOLISA Tocilizumab (ACTEMRA) ELISA - CE MARKED 96W
744.00 € 744.0 EUR
[0879-KBI1010] KRIBIOLISA Rituximab ELISA (RITUXAN)
KRIBIOLISA Rituximab ELISA (RITUXAN)
494.00 € 494.0 EUR
[0879-KBI1029] KRIBIOLISA Ranibizumab ELISA (LUCENTIS) 96W
KRIBIOLISA Ranibizumab ELISA (LUCENTIS) 96W
744.00 € 744.0 EUR
[0879-KBI1050] KRIBIOLISA Nivolumab (OPDIVO) ELISA 96T
KRIBIOLISA Nivolumab (OPDIVO) ELISA 96T
1,337.00 € 1337.0 EUR
[0879-KBI1011] KRIBIOLISA Infliximab ELISA (REMICADE) 96W
KRIBIOLISA Infliximab ELISA (REMICADE) 96W
640.00 € 640.0 EUR
  • 43
  • 44
  • 45
  • 46
  • 47

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)